Mkts

Neurocrine Biosciences, Inc.

NASDAQ: NBIX
$164.63+4.87 (+3.05%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
158.66165.86
52-week range
122.14186.12
Today
Open159.98
Previous close164.63
Volume—
Valuation
Market cap16.66B
P/E ratio23.72×
EPS (TTM)6.74
Income & risk
Dividend / yield—
Beta0.29
Avg volume1.32M
Discussion

NBIX News

Stories mentioning NBIX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue814,500805,500794,900687,500572,600627,700622,100590,200
Cost of Goods Sold13,80017,60014,00011,3009,2009,3008,0009,200
Gross Profit800,700787,900780,900676,200563,400618,400614,100581,000
Operating Expenses
Research & Development
Sales General & Admin318,500301,800291,600286,300276,500287,800234,300242,000
Total Operating Expenses
Operating Income (Loss)193,400210,900239,000145,60023,600142,000183,800145,400
Interest Income
Interest Expense
Other Expense
Pretax Income246,800239,400291,800159,50014,700162,600190,30098,600
Tax Provision48,90085,70082,30052,0006,80059,50060,50033,600
Net Income (Loss)197,900153,700209,500107,5007,900103,100129,80065,000
Earnings Per Share (Basic)1.971.542.111.090.081.031.280.64
Earnings Per Share (Diluted)1.911.502.041.060.080.991.240.63
Weighted Average Shares Outstanding (Basic)100,50099,50099,40099,00099,700100,400101,100100,800
Weighted Average Shares Outstanding (Diluted)103,400102,500102,500101,000102,500103,700104,300103,900

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About NBIX

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is a stock listed on the Nasdaq Stock Market under the ticker symbol NBIX. It last traded at $164.63 (Nov 6, 2026, 4:00 PM ET), up 3.0% on the day. That gives Neurocrine Biosciences a market capitalisation of $16.7B and a price-to-earnings ratio of 23.7.

Over the past 52 weeks NBIX has traded between $122.14 and $186.12.

Revenue for the quarter ended Mar 31, 2026 was $814.5M; net income $197.9M. Revenue was up 42.2% from $572.6M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$814.5M$197.9M24.3%
Dec 31, 2025$805.5M$153.7M19.1%
Sep 30, 2025$794.9M$209.5M26.4%
Jun 30, 2025$687.5M$107.5M15.6%

From Neurocrine Biosciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…